Physician profile
Melissa Mcshane
NPI 1578980462
$30,938.23
in general payments reported to CMS, 2019-2025
8 companies · $15K in 2025
The $15K reported for 2025 was more than what 85% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $10K · 2024: $5,810 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Travel and Lodging: $1,260 · Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,890.00 |
| Travel and Lodging | $1,260.22 |
| Food and Beverage | $788.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $28,765.05 | 2023-2025 | Truqap, Datroway, Enhertu |
| Gilead Sciences, INC. | $1,940.02 | 2025 | Trodelvy |
| Blueprint Medicines Corporation | $98.04 | 2023 | |
| Daiichi Sankyo INC. | $83.46 | 2024 | Enhertu |
| Genentech USA, INC. | $38.08 | 2023-2024 | Perjeta, Phesgo, Kadcyla |
| Caris Mpi, INC. | $13.58 | 2025 | Mi Cancer Seek |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Mcshane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.